TRIVAC decision-support model for evaluating the cost-effectiveness of Haemophilus influenzae type b, pneumococcal and rotavirus vaccination

Vaccine

Volumn 31, Issue SUPPL.3, 2013, Pages

  Clark, Andrew ^a   Jauregui, Barbara ^b   Griffiths, Ulla ^a   Janusz, Cara B ^b   Bolaños Sierra, Brenda ^a   Hajjeh, Rana ^c   Andrus, Jon K ^b   Sanderson, Colin ^a  

^a LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^b PAN AMERICAN HEALTH ORGANIZATION   (United States)

^c CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

Cost effectiveness; Decision; Health economics; New vaccines; Support models

Indexed keywords

HAEMOPHILUS INFLUENZAE TYPE B VACCINE; PNEUMOCOCCUS VACCINE; ROTAVIRUS VACCINE;

CHILDHOOD DISEASE; COST EFFECTIVENESS ANALYSIS; DECISION SUPPORT SYSTEM; DEMOGRAPHY; DRUG COST; DRUG EFFICACY; HAEMOPHILUS INFECTION; HAEMOPHILUS MENINGITIS; HEALTH CARE UTILIZATION; HUMAN; MORTALITY; PNEUMOCOCCAL INFECTION; PNEUMOCOCCAL MENINGITIS; PRIORITY JOURNAL; REVIEW; ROTAVIRUS INFECTION; STREPTOCOCCUS PNEUMONIA; VACCINATION;

CHILD; COST OF ILLNESS; COST-BENEFIT ANALYSIS; DECISION MAKING; DECISION SUPPORT TECHNIQUES; HAEMOPHILUS INFECTIONS; HAEMOPHILUS VACCINES; HEALTH PLANNING GUIDELINES; HUMANS; IMMUNIZATION PROGRAMS; PNEUMOCOCCAL INFECTIONS; PNEUMOCOCCAL VACCINES; PUBLIC HEALTH; ROTAVIRUS INFECTIONS; ROTAVIRUS VACCINES; SOFTWARE; VACCINES, CONJUGATE;

EID: 84879241383     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2013.05.045     Document Type: Review

References (23)

1. Appendix G - Impact of vaccines in the 20th & 21st centuries, Centers for Disease Control and Prevention. Epidemiology and Prevention of Vaccine-Preventable Diseases. 12th ed., second printing ed. Washington, DC: Public Health Foundation; 2012.
2. Black R.E., Cousens S., Johnson H.L., Lawn J.E., Rudan I., Bassani D.G., et al. Global, regional, and national causes of child mortality in 2008: a systematic analysis. Lancet 2010, 375:1969-1987.
3. The Disease Control Priorities Project. Using cost-effectiveness analysis for setting health priorities. Available from: [accessed March 2008]. http://www.dcp2.org/file/150/DCPP-CostEffectiveness.pdf.
4. Glassman A, Chalkidou K. Priority-setting in health. Building institutions for smarter public spending. A report of the Center for Global Development's Priority-Setting Institutions for Global Health Working Group.
5. Jauregui B., Sinha A., Clark A.D., Bolanos B.M., Resch S., Toscano C.M., et al. Strengthening the technical capacity at country-level to make informed policy decisions on new vaccine introduction: lessons learned by PAHO's ProVac Initiative. Vaccine 2011, 29:1099-1106.
6. Hajjeh R.A., Privor-Dumm L., Edmond K., O'Loughlin R., Shetty S., Griffiths U.K., et al. Supporting new vaccine introduction decisions: lessons learned from the Hib Initiative experience. Vaccine 2010, 28:7123-7129.
7. The World Bank. How we classify countries. Available from: [accessed 07.09.12]. http://data.worldbank.org/about/country-classifications.
8. WHO. List of member states by WHO region and mortality stratum. Available from: http://www.who.int/whr/2003/en/member_states_182-184_en.pdf.
9. Microsoft Excel 2007. Redmond, WA, USA: Microsoft Corporation.
10. Murray C.J.L., Lopez A.D. The global burden of disease: a comprehensive assessment of mortality and disability from diseases, injuries and risk factors in 1990 and projected to 2020 1996, Harvard University Press, Cambridge.
11. Crawford S.E., Daum R.S. Haemophilus influenzae. Nelson textbook of pediatrics 2004, Saunders Elsevier. R.M. Kliegman (Ed.).
12. Ruuska T., Vesikari T. Rotavirus disease in Finnish children: use of numerical scores for clinical severity of diarrhoeal episodes. Scand J Infect Dis 1990, 22:259-267.
13. Clark H.F., Borian F.E., Bell L.M., Modesto K., Gouvea V., Plotkin S.A. Protective effect of WC3 vaccine against rotavirus diarrhea in infants during a predominantly serotype 1 rotavirus season. J Infect Dis 1988, 158:570-587.
14. Wolfson L.J., O'Brien K.L., Watt J.P., Henkle E., Deloria-Knoll M., McCall N., et al. Supplementary webappendix to: O'Brien KL, Wolfson LJ, Watt JP, et al. Burden of disease caused by Streptococcus pneumoniae in children younger than 5 years: global estimates. Lancet 2009, 374:893-902.
15. Hicks L.A., Harrison L.H., Flannery B., Hadler J.L., Schaffner W., Craig A.S., et al. Incidence of pneumococcal disease due to non-pneumococcal conjugate vaccine (PCV7) serotypes in the United States during the era of widespread PCV7 vaccination, 1998-2004. J Infect Dis 2007, 196:1346-1354.
16. Fox-Rushby J.A., Hanson K. Calculating and presenting disability adjusted life years (DALYs) in cost-effectiveness analysis. Health Policy Plan 2001, 16:326-331.
17. Jit M., Brisson M. Modelling the epidemiology of infectious diseases for decision analysis: a primer. Pharmacoeconomics 2011, 29:371-386.
18. Patel M., Pedreira C., De Oliveira L.H., Tate J., Orozco M., Mercado J., et al. Association between pentavalent rotavirus vaccine and severe rotavirus diarrhea among children in Nicaragua. JAMA 2009, 301:2243-2251.
19. Chaiyakunapruk N., Somkrua R., Hutubessy R., Henao A.M., Hombach J., Melegaro A., et al. Cost effectiveness of pediatric pneumococcal conjugate vaccines: a comparative assessment of decision-making tools. BMC Med 2011, 9:53.
20. WHO. Report on the WHO Quantitative and Vaccine Related Research (QUIVER) Advisory Committee Meeting, Geneva, 4-6 October 2011. WHO/IVB/12.03. Available from: http://whqlibdoc.who.int/hq/2012/who_ivb_12.03_eng.pdf.
21. Rheingans R., Atherly D., Anderson J. Distributional impact of rotavirus vaccination in 25 GAVI countries: estimating disparities in benefits and cost-effectiveness. Vaccine 2012, 30(Suppl. 1):A15-A23.
22. Clark A., Sanderson C. Timing of children's vaccinations in 45 low-income and middle-income countries: an analysis of survey data. Lancet 2009, 373:1543-1549.
23. WHO. Meeting of the Strategic Advisory Group of Experts on Immunization - April 2012 - conclusions and recommendations - [Weekly Epidemiological Record]. http://www.who.int/wer/2012/wer8721.pdf.